- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
洛伐他汀治疗慢性心力衰竭160例的的疗效观察
洛伐他汀治疗慢性心力衰竭160例的的疗效观察
[摘要] 目的:研究洛伐他汀(Lovastatin)对慢性心力衰竭(CHF)患者的治疗效果。方法:选择慢性心力衰竭(心衰)患者160例,采用随机对照研究方法将其分为对照组(80例)和治疗组(80例),对照组给予常规强心、利尿、扩血管等抗心衰治疗;治疗组除给予常规抗心衰治疗外,加用洛伐他汀片。对治疗前后两组患者的临床症状和心脏彩超指标的变化情况进行比较、分析。结果:经16周治疗后两组患者临床症状及心功能分级较治疗前均有所改善,治疗组较对照组改善更明显,差异有统计学意义(P0.05);两组患者心脏彩超显示左室舒张末内径(LVED)与左室收缩末内径(LVES)较治疗前均有所缩小,左室射血分数(LVEF)均有所提高,治疗组较对照组改变更明显,差异有统计学意义(P0.05)。结论:慢性心力衰竭患者在给予常规强心、利尿、扩血管等抗心衰药物治疗基础上加用洛伐他汀可进一步改善患者心功能,且能改善患者预后。
[关键词] 洛伐他汀;慢性心力衰竭;疗效
[中图分类号] R541[文献标识码]B[文章编号]1673-7210(2011)07(c)-156-02
The effect observation on Lovastatin in the treatment of 160 patients with congestive heart failure
CHENG Lirong
Department of Medicine Two, The TCM Hospital of Xinle City, Hebei Province, Xinle 050700, China
[Abstract] Objective: To study the effects observation on Lovastatin in the treatment of patients with congestive heart failure. Methods: 160 patients with congestive heart failure (CHF) were divided into control group (80 cases) and treatment group (80 cases). The control group was given conventional treatment with stronging heart, diuresis, enlarging blood vessels and so on; the treatment group was given conventional treatment with Lovastatin based on the conventional treatment. Before and after the treatment, clinical symptoms and index of cardiac color sonography of two groups were compared. Results: The symptoms and the grade of NYHA had shown some improvement after the treatment of 16 weeks. The treatment group was higher than that of the control group. There were significant differences between the two groups (P0.05). The left ventricular end diastolic diameter (LVED) and the left ventricular end systolic diameter (LVES) of two groups had lessened than that before the treatment, but the left ventricular ejection fraction (LVEF) had risen, the treatment group was significantly higher than that of the control group. There were significant differences between the two groups (P0.05). Conclusion: The heart functions of the patients with CHF are
原创力文档


文档评论(0)